DOI QR코드

DOI QR Code

Improving Medication Adherence in Isolated Patients With Cognitive Impairment Using Automated Telephone Reminders

  • Moon Jeong Kim (Department of Education and Training, Severance Hospital) ;
  • Jeong Yun Song (Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine) ;
  • Jae-won Jang (Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine) ;
  • Seo-Young Lee (Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine) ;
  • Jin Hyeong Jhoo (Department of Psychiatry, Kangwon National University Hospital, Kangwon National University College of Medicine) ;
  • Gi Hwan Byeon (Department of Psychiatry, Kangwon National University Hospital, Kangwon National University College of Medicine) ;
  • Yeshin Kim (Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine)
  • Received : 2022.05.17
  • Accepted : 2022.09.01
  • Published : 2022.10.31

Abstract

Background and Purpose: Medication adherence is essential for effective medical treatment. However, it is challenging for cognitively impaired patients. We investigated whether an automated telephone reminder service improves medication adherence and reduces the decline of cognitive function in isolated patients with cognitive impairment. Methods: This was a single-center, randomized clinical trial. We enrolled mild cognitive impairment (MCI) or Alzheimer's disease (AD) patients who lived alone or with a cognitively impaired spouse. We provided an automated telephone reminder service for taking medication to the intervention group for 6 months. The control group was provided with general guidelines for taking the medication every month. The participants underwent neuropsychological assessment at the beginning and end of the study. Statistical significance was tested using nonparametric Wilcoxon rank sum and Wilcoxon matched-pairs signed-rank tests. Results: Thirty participants were allocated randomly to groups, and data for 29 participants were analyzed. The mean age was 79.6 (standard deviation, 6.0) years and 79.3% of the participants were female. There was no significant difference in medication adherence between the 2 groups. However, a subgroup analysis among participants with more than 70% response rates showed better medication adherence compared to the control group (intervention: 94.6%; control: 90.2%, p=0.0478). There was no significant difference in the change in cognitive function between the 2 groups. Conclusions: If a patient's compliance is good, telephone reminders might be effective in improving medication adherence. It is necessary to develop reminder tools that can improve compliance for cognitively impaired patients.

Keywords

Acknowledgement

Eisai provided the telephone reminder service.

References

  1. Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1997;58 Suppl 1:11-14.
  2. El-Saifi N, Moyle W, Jones C, Tuffaha H. Medication adherence in older patients with dementia: a systematic literature review. J Pharm Pract 2018;31:322-334.
  3. Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother 2012;10:165-177.
  4. Borah B, Sacco P, Zarotsky V. Predictors of adherence among Alzheimer's disease patients receiving oral therapy. Curr Med Res Opin 2010;26:1957-1965.
  5. Haider B, Schmidt R, Schweiger C, Forstner T, Labek A, Lampl C. Medication adherence in patients with dementia: an Austrian cohort study. Alzheimer Dis Assoc Disord 2014;28:128-133.
  6. Insel KC, Cole L. Individualizing memory strategies to improve medication adherence. Appl Nurs Res 2005;18:199-204.
  7. Smith GE, Lunde AM, Hathaway JC, Vickers KS. Telehealth home monitoring of solitary persons with mild dementia. Am J Alzheimers Dis Other Demen 2007;22:20-26.
  8. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
  9. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
  10. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:47-53.
  11. Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement 2008;4:96-109.
  12. Kripalani S, Schmotzer B, Jacobson TA. Improving Medication Adherence through Graphically Enhanced Interventions in Coronary Heart Disease (IMAGE-CHD): a randomized controlled trial. J Gen Intern Med 2012;27:1609-1617.
  13. Kamimura T, Ishiwata R, Inoue T. Medication reminder device for the elderly patients with mild cognitive impairment. Am J Alzheimers Dis Other Demen 2012;27:238-242.
  14. Kamimura T. Older adults with Alzheimer's disease who have used an automatic medication dispenser for 3 or more years. Clin Gerontol 2019;42:127-133.